0001127602-23-003927.txt : 20230208 0001127602-23-003927.hdr.sgml : 20230208 20230208104518 ACCESSION NUMBER: 0001127602-23-003927 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230201 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gajewski Kristen CENTRAL INDEX KEY: 0001964933 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16091 FILM NUMBER: 23597572 MAIL ADDRESS: STREET 1: 33587 WALKER ROAD CITY: AVON LAKE STATE: OH ZIP: 44012 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVIENT CORP CENTRAL INDEX KEY: 0001122976 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 341730488 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33587 WALKER ROAD CITY: AVON LAKE STATE: OH ZIP: 44012 BUSINESS PHONE: 440-930-1000 MAIL ADDRESS: STREET 1: 33587 WALKER ROAD CITY: AVON LAKE STATE: OH ZIP: 44012 FORMER COMPANY: FORMER CONFORMED NAME: POLYONE CORP DATE OF NAME CHANGE: 20000830 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2023-02-01 0 0001122976 AVIENT CORP AVNT 0001964933 Gajewski Kristen AVIENT CENTER AVON LAKE OH 44012 1 SVP & CHRO Common Stock 929 D Common Stock 840.407 I Savings Plan Trust Common Stock 95.234 I Supplemental Plan Restricted Stock Units 2023-02-10 Common Stock 769 D Restricted Stock Units 2024-02-08 Common Stock 670 D Restricted Stock Units 2025-02-14 Common Stock 668 D Stock Appreciation Rights 41.89 2028-02-14 Common Stock 1150 D Stock Appreciation Rights 31.54 2029-02-11 Common Stock 700 D Stock Appreciation Rights 31.48 2030-02-10 Common Stock 1466 D Stock Appreciation Rights 42.27 2031-02-08 Common Stock 2570 D Stock Appreciation Rights 52.64 2032-02-11 Common Stock 2300 D The information in this report is based on a plan statement as of February 1, 2023. The restricted stock units vest 3 years from the date of grant on February 10, 2023. The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units. The restricted stock units vest 3 years from the date of grant on February 8, 2024. The restricted stock units vest 3 years from the date of grant on February 14, 2025. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years. /s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski 2023-02-08 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY Power of Attorney Know all by these presents that the undersigned hereby constitutes and appoints each of Robert M. Patterson, Jamie A. Beggs and Lisa K. Kunkle, signing singly, the undersigned's true and lawful attorney-in-fact to: 1. Prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; and 2. Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of PolyOne Corporation (the "Corporation"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; and 3. Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the SEC and any stock exchange or similar authority; and 4. Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Corporation assuming, any of the undersigned's responsibility to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Corporation, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 18th day of January 2023. /s/ Kristen Gajewski ____________________________ Kristen Gajewski